Inhibitor 3 had the shortest half-life of 2.1 hours. These results parallel the relative microsome stability data in mice and demonstrate sufficient exposure to the liver for all three compounds. Additionally, compounds 1 and 3 were administered PO at 10 mg/kg, which resulted in sufficient half-lives and liver exposure in male mice to support that these compounds are also orally bioavailable (Supplementary Table ).